Therefore, we can speculate that in the genome of Tspan7 transgenic mice, there may also be mutations in Otc, resulting in a hyperammonemic phenotype, as seen in OTCD patients. This evidence concerns the gene TSPAN7 and ornithine carbamoyltransferase deficiency.